期刊文献+

再延长降调——超长方案的尝试 被引量:3

Clinical outcome of extended super-long down-regulation protocol
暂未订购
导出
摘要 目的探讨适合部分特殊不育患者的控制性超排卵方案。方法回顾分析2012年1月至2012年12月应用加长超长方案的患者共14例(降调不全患者8例,子宫内膜异位症患者6例),设同期的传统超长方案组及常规长方案组、改良超长方案组为对照组。结果子宫内膜异位症采用加长超长方案组与传统超长方案组相比,降调后的黄体生成素(LH)及雌二醇(E_2)水平较高;降调不全的加长超长方案组与常规长方案组及改良超长方案组比较,除了加长超长方案组的着床率较高外,其他临床观察指标无差异。结论对于已行卵巢巧克力囊肿剥除术的子宫内膜异位症患者巧克力囊肿复发的及部分降调不全的患者采用加长超长方案促排卵,在改善临床妊娠率的同时,能有效减少降调周期取消。 Objective: To investigate the clinical outcome of extended super-long down-regulation protocol for special infertile patients. Methods: The data of 14 patients undergone extended super-long down-regulation protocol from Jan. 2012 to Dec. 2012 were retrospectively analyzed. Meanwhile,the traditional super-long down-regulation protocol group, the conventional long down-regulation protocol group and the modified super-long down- regulation protocol group were served as control groups. Results: The LH and estradiol (E2) levels after down regulation were higher in the endometriosis patients received the extended super-long protocol than those in the traditional super-long protocol group. The clinical outcomes in the patients who had ever suffered incomplete down regulation and received the extended super-long protocol were not significantly different except higher implantation rate compared with conventional long down-regulation protocol group or the modified super-long down-regulation protocol group. Conclusions: The extended super-long down-regulation protocol can improve clinical pregnancy rate and reduce cycle cancelled rate in the patients with ovarian chocolate cystectomy or incomplete down- regulation.
出处 《生殖医学杂志》 CAS 2013年第10期766-770,共5页 Journal of Reproductive Medicine
关键词 子宫内膜异位症 超长方案 体外授精-胚胎移植 Endometriosis Super-long protocol In vitro fertilization-embryo transfer
  • 相关文献

参考文献9

  • 1Rickes D, Nickle I, Kleibsten J, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin- releasing hormone analogs in patients with endometriosis[J]. Fertil Steril, 2002,78 : 757-762.
  • 2彭献东,陈华,韩金兰,余敏,严敬明.超长方案促性腺激素释放激素激动剂降调节对子宫内膜异位症体外受精-胚胎移植结局的影响[J].生殖医学杂志,2007,16(5):319-320. 被引量:10
  • 3Gong Fei, Tang Yi, Zhang hong, et al. Modified super-Long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients[J]. Cent south Univ (Med Sci), 2009,34 : 185-189.
  • 4Zikopoulos K, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization inpatients with endometriosis[J]. Acta Obstet Gyneeol Scand, 2004, 83: 651-655.
  • 5Surrey E, Silverberg K, Surrey M, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro {ertilization-embryo transfer in patients with endometriosis[J]. Fertil Steril, 2002,78 : 699-704.
  • 6李洁,周灿权,钟依平,欧建平,林雯青,庄广伦.不同小剂量促性腺激素释放激素激动剂在体外受精-胚胎移植中应用的比较[J].中华妇产科杂志,2006,41(4):269-270. 被引量:39
  • 7Young KA, Chaffin CL, Molskness TA, et al, Controlled ovulation of the dominant follicle:a critical role for LH in the late follicular phase of the menstrual cycle[J]. Hum Reprod, 2003,18 : 2257-2263.
  • 8Reizel Y, Elbaz J, Dekel N. Sustained activity of the EGFreceptor is an absolute requisite for I.H induced oocyte maturation and cumulus expansion[J]. Mol Endocrinol,2010, 24:402-411.
  • 9黄筱金,韩艳,柳鸣,黄建贞,易红霞.子宫内膜异位症合并不育患者体外受精-胚胎移植治疗结局分析[J].实用临床医学(江西),2007,8(12):74-77. 被引量:10

二级参考文献18

  • 1马彩虹,陈贵安,乔杰,刘平.子宫内膜异位症对体外受精-胚胎移植的影响[J].中国妇产科临床杂志,2004,5(3):201-203. 被引量:4
  • 2Porter RN,Smith W,Craft IL,et al.Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.Lancet,1984,2:1284-1285.
  • 3Janssens RM,Vermeiden JP,Lambalk CB,et al.Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF.Hum Reprod,1998,13:2386-2391.
  • 4Yim SF,Lok IH,Cheung LP,et al.Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF.Hum Reprod,2001,16:492-494.
  • 5Janssens RM,Lambalk CB,Vermeiden JP,et al.Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF:a prospective,randomized,double-blind,placebo-controlled study.Hum Reprod,2000,15:2333-2340.
  • 6Albuquerque LE,Saconato H,Maciel MC.Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.Cochrane Database Syst Rev,2005,25:CD002808.
  • 7Dor J,Bider D,Shulman A,et al.Effects of gonadotrophin-releasing hormone agonists on human ovarian steroid secretion in vivo and in vitro-results of a prospective,randomized in-vitro fertilization study.Hum Reprod,2000,15:1225-1230.
  • 8Pabuccu R,Onalan G,Kaya C.GnRH agonist and antagonist protocols for stage Ⅰ-Ⅱ endometriosis and endometrioma in IVF/ICSI[J].Fertil Steril,2007 Apr 9[Epub ahead of print].
  • 9Surrey ES,Silverberg KM,Surrey MW,et al.Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis[J].Fertil Steril,2002,78(4):699-704.
  • 10Rickes D,Nickle I,Kleibsten J,et al.Increased pregnancy rates after ultralong postoperative therapy with gonadotropinreleasing hormone analogs in patients with endometriosis[J].Fertil Steril,2002,78 (4):757-762.

共引文献54

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部